SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-17-007533
Filing Date
2017-04-27
Accepted
2017-04-27 16:04:04
Documents
5
Period of Report
2017-06-01
Effectiveness Date
2017-04-27

Document Format Files

Seq Description Document Type Size
1 XENE-DEF14A-2017 xene-def14a_20161231.htm DEF 14A 2649966
2 GRAPHIC g201704200022208487687.jpg GRAPHIC 3078
3 GRAPHIC g201704200022382927689.jpg GRAPHIC 2099
4 GRAPHIC g201704200022283547688.jpg GRAPHIC 36046
5 GRAPHIC g201704200022205357686.jpg GRAPHIC 3078
  Complete submission text file 0001564590-17-007533.txt   2712656
Mailing Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W
Business Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W (604) 484-3300
Xenon Pharmaceuticals Inc. (Filer) CIK: 0001582313 (see all company filings)

IRS No.: 980661854 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36687 | Film No.: 17789009
SIC: 2834 Pharmaceutical Preparations